Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates-Reference-Cited by-同舟云学术

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates

Published:2022-10-30 Issue:1 Volume:58 Page:115-118
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sava Mihaela^ORCID,Bättig Veronika,Gerull Sabine,Passweg Jakob R.,Khanna Nina^ORCID,Garzoni Christian,Gerber Bernhard,Mueller Nicolas J.^ORCID,Schanz Urs,Berger Christoph,Chalandon Yves^ORCID,van Delden Christian,Neofytos Dionysios^ORCID,Stampf Susanne,Franzeck Fabian C.^ORCID,Weisser Maja^ORCID,

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01851-y.pdf

Reference12 articles.

1. Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, et al. Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study. Transplant Cell Ther. 2022;28:50.e1–50.e8.

2. Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transplant Infect Dis. 2014;16:106–14.

3. Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15:47–53.